January 17th 2025
Mineralys Therapeutics also expects topline data from its phase 2 study of lorundrostat for the treatment of uncontrolled hypertension or resistant hypertension when used as an add-on therapy.
Gregory Marcus, MD, MAS, Reviews the Coffee and Real-time Atrial & Ventricular Ectopy (CRAVE) Trial
November 15th 2021AHA 2021: Marcus, lead author of CRAVE, says it found little effect of caffeine on atrial arrhythmias, a significant effect on PVCs, a negative effect on sleep, and a boosting effect on physical activity.
Effective BP Reduction Achieved via Hypertension Remote Care Program During Lockdown
November 10th 2021AHA Scientific Sessions 2021: Blood pressure reductions to clinical targets were achieved by patients with sustained hypertension through a remote health care delivery program during the COVID-19 pandemic.
Metabolically Healthy Obesity May Increase Risk of Heart Failure, but Not Heart Attack or Stroke
October 5th 2021EASD 2021: Patients with metabolically healthy obesity are nearly 33% more likely to develop heart failure and atrial fibrillation than healthy persons of normal weight, suggests new analysis.